MSD Animal Health receives Animal Pharm award for the IDAL® portfolio

Milton Keynes, UK, January 29 2019 –MSD Animal Health’s pig team are elated to receive the ‘best new food animal product’ award for the IDAL family from the leading online animal health media source – Animal Pharm.

Released in 2018, the IDAL 3G twin is celebrated as the first needle-free and intradermal device with two injector heads for swine vaccinations. Removing the needle from the process improves animal welfare as the vaccination is safer and less stressful for the pigs, plus more convenient and efficient for the farmers when compared to original injections.

MSD Animal Health is the only company offering dual intradermal vaccination against the key swine diseases, porcine circovirus type 2 and porcine enzootic pneumonia – administering two vaccines at the same time offers quick protection for the pigs against potentially fatal illnesses.

Another new device in the pig portfolio – the IDAL 3G – was praised by Animal Pharm for its comfortable handling, two button control and graphical display. The device is licensed to administer three intradermal vaccines in the UK, PORCILIS® PRRS, PORCILIS PCV ID, PORCILIS M Hyo ID Once. MSD Animal Health is the sole company to offer intradermal vaccines against key swine diseases.

Caroline Moore, UK IDAL Development Manager said “we are delighted that Animal Pharm has recognised MSD Animal Health for the innovation and technology that the needle-free IDAL devices offer to the pig industry.”

Animal Pharm has commended the innovation in vaccine development. The IDAL family displays MSD Animal Health’s commitment to improving animal health and welfare and making life easier for workers on farm. The expectation is that IDAL technology can eventually take over from traditional needle-applied vaccines.

About MSD Animal Health
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit or connect with us on LinkedIn and Twitter.